E-LIB Suche - Ergebnisse für: Stege, Ralf

1

Dat mokt wie gistern

de lesste Apparatspott

Stege, Ralf ; Klussmann, Detlef ; Herrmann, Martin.. , 2008

Exemplar: Zentrale/Mediathek: ph 2091

2

Stringent monitoring can decrease mortality of immune check..:

Wang, Ying ; Ertl, Carolin ; Schmitt, Christina...
Frontiers in Cardiovascular Medicine. 11 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

Treatment management forBRAF-mutant melanoma patients with ..:

Haist, Maximilian ; Stege, Henner ; Rogall, Friederike...
Journal for ImmunoTherapy of Cancer. 11 (2023) 9 - p. e007630 , 2023

Link: https://doi.org/10.1136/..

4

Tolerability of BRAF and MEK Inhibitors for Metastasized Me..:

Salzmann, Martin ; Wald, Alexander ; Stege, Henner...
Cancers. 15 (2023) 5 - p. 1426 , 2023

Link: https://doi.org/10.3390/..

5

Response to First-Line Treatment with Immune-Checkpoint Inh..:

Haist, Maximilian ; Stege, Henner ; Lang, Berenice Mareen...
Cancers. 14 (2022) 22 - p. 5543 , 2022

Link: https://doi.org/10.3390/..

6

Combined immunotherapy with nivolumab and ipilimumab with a..:

Amaral, Teresa ; Kiecker, Felix ; Schaefer, Sarah...
Journal for ImmunoTherapy of Cancer. 8 (2020) 1 - p. e000333 , 2020

Link: https://doi.org/10.1136/..

7

The effect of amelogenins (Xelma™) on hard‐to‐heal venous l..:

Vowden, Peter ; Romanelli, Marco ; Peter, Ralf...
Wound Repair and Regeneration. 14 (2006) 3 - p. 240-246 , 2006

Link: https://doi.org/10.1111/..

8

Antisense Therapy Attenuates Phospholamban p.(Arg14del) Car..:

Eijgenraam, Tim R. ; Stege, Nienke M. ; Oliveira Nunes Teixeira, Vivian...
International Journal of Molecular Sciences. 23 (2022) 5 - p. 2427 , 2022

Link: https://doi.org/10.3390/..

9

Tolerability of BRAF and MEK Inhibitors for Metastasized Me..:

Salzmann, Martin ; Wald, Alexander ; Stege, Henner...
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/21832. , 2023

Link: https://opus4.kobv.de/op..

10

Treatment management for BRAF-mutant melanoma patients with..:

Haist, Maximilian ; Stege, Henner ; Rogall, Friederike...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510881/. , 2023

Link: http://www.ncbi.nlm.nih...

11

Response to First-Line Treatment with Immune-Checkpoint Inh..:

Haist, Maximilian ; Stege, Henner ; Lang, Berenice Mareen...
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/21056. , 2022

Link: https://opus4.kobv.de/op..

12

Response to First-Line Treatment with Immune-Checkpoint Inh..:

Haist, Maximilian ; Stege, Henner ; Lang, Berenice Mareen...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688854/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Response to first-line treatment with immune-checkpoint inh..:

Haist, Maximilian ; Stege, Henner ; Lang, Berenice Mareen...
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/29750. , 2022

Link: https://opus.bibliothek...

14

Combined immunotherapy with nivolumab and ipilimumab with a..:

Amaral, Teresa ; Kiecker, Felix ; Schaefer, Sarah...
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/77109. , 2020

Link: https://opus.bibliothek...

15

Combined immunotherapy with nivolumab and ipilimumab with a..:

Amaral, Teresa ; Kiecker, Felix ; Schaefer, Sarah...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206917/. , 2020

Link: http://www.ncbi.nlm.nih...